SYK
44
-27
BIIB
56
5
PCAR
45
-19
MPC
76
-2
TSCO
77
-3
REGN
44
-12
HST
57
-7
SWK
46
-19
CI
45
-23
MO
50
-19
A
62
2
XEL
39
-30
V
46
-30
GRMN
46
-19
XRX
52
-14
NTRS
55
-19
HON
78
-5
SYY
50
-20
COF
63
-2
BAX
57
4
SYK
44
-27
BIIB
56
5
PCAR
45
-19
MPC
76
-2
TSCO
77
-3
REGN
44
-12
HST
57
-7
SWK
46
-19
CI
45
-23
MO
50
-19
A
62
2
XEL
39
-30
V
46
-30
GRMN
46
-19
XRX
52
-14
NTRS
55
-19
HON
78
-5
SYY
50
-20
COF
63
-2
BAX
57
4
Financhill
Back

NeuroPace Stock Predictions

7 Stocks to Consider Immediately (must-see chart)

See the green days for 7 major stocks right here, free of charge
Sell
25

NPCE
NeuroPace

Last Price:
$10.09
Seasonality Move:
13.78%

7 Day Trial

ALL ACCESS PASS

$ 7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks

Click Here to Download Your FREE Stock Report Now

NeuroPace Stock Forecast

  • Over the next 52 weeks, NeuroPace has on average historically risen by 4.2% based on the past 4 years of stock performance.
  • NeuroPace has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is NeuroPace Stock Undervalued?
    The current NeuroPace [NPCE] share price is $10.36. The Score for NPCE is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • NPCE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will NeuroPace Stock Go Up Next Year?

  • Over the next 52 weeks, NeuroPace has on average historically risen by 4.2% based on the past 4 years of stock performance.

NeuroPace Stock Rating

Sell
25
NeuroPace (NPCE) is a Sell

Is NeuroPace overpriced?

  • NeuroPace has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

NeuroPace Stock Price History

Is NPCE stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NPCE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
neuropace.com

52-Week Data

52-Week High:
18.98
52-Week Low:
5.45

Prediction Charts

Market Cap:
339.8M
Price in USD:
10.36
Volume:
138.6K
Beta:
1.94

Technical Analysis

SMA50:
12.66
SMA100:
12.28
SMA200:
10.95
52-Wk Change:
52.13%

Stock Predictions

  • Is NeuroPace stock public?
    Yes, NeuroPace is a publicly traded company.
  • What is the NeuroPace stock quote today?
    The NeuroPace stock price is 10.36 USD today.
  • How to buy NeuroPace stock online?
    You can buy NeuroPace shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-17 11.09 10.78 11.19 10.72
Jun-18 10.75 10.60 10.92 10.45
Jun-20 10.60 10.41 10.73 10.38
Jun-23 10.37 10.57 10.61 9.85
Jun-24 10.50 10.76 10.90 10.20
Jun-25 10.14 10.57 10.59 9.88
Jun-26 10.60 10.94 11.03 10.27
Jun-27 11.00 10.71 11.04 10.32
Jun-30 10.81 11.14 11.53 10.73
Jul-1 11.10 10.48 11.37 10.10
Jul-2 10.47 10.42 10.60 10.20
Jul-3 10.44 10.39 10.64 10.24
Jul-7 10.32 10.22 10.60 10.05
Jul-8 10.22 10.36 10.38 10.10

NeuroPace Earnings

NeuroPace Earnings Report: Per Share NeuroPace Earnings Q1 Q2 Q3 and Q4 last year and next year.

NeuroPace Forecast Revenue Growth

NeuroPace Stock Analysis: Historical quarterly revenues per share for NeuroPace and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.05 per share, an increase this year of $0.17 per share, and an increase next year of $0.22 per share.

* NeuroPace stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.